@article{NCRI4382,
author = {Hong P. T. Nguyen and Andrew P. Morokoff and Stanley S. Stylli and Andrew H. Kaye and Rodney B. Luwor},
title = {Peripheral biomarkers in glioblastoma patients—is it all just HOTAIR?},
journal = {Non-coding RNA Investigation},
volume = {2},
number = {0},
year = {2018},
keywords = {},
abstract = {Glioblastoma multiforme is the most aggressive form of brain cancer. The standard of care treatment for newly diagnosed patients with glioblastoma is tumour de-bulking by surgery, followed combination therapy consisting of radiation and temozolomide chemotherapy (1). The tumour invariably recur, often in the same area or adjacent to as the original surgical-resected tumor (2,3).},
issn = {2522-6673}, url = {https://ncri.amegroups.org/article/view/4382}
}